Related Experiment Video

Updated: Nov 6, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K

Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine

Yael Shostak1, Noa Shafran2, Moshe Heching3

  • 1Department of Medicine D, Rabin Medical Center, Petach Tikva, Israel; Pulmonary Division, Rabin Medical Center, Petach Tikva 49100, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

The Lancet. Respiratory Medicine
|May 8, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.3K

Related Experiment Videos

Last Updated: Nov 6, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.3K

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

79.4K
Overview
79.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

78.9K
Overview
78.9K
Vaccinations01:51

Vaccinations

48.7K
Overview
48.7K

Articles linked to this work by shared authors, journal, and citation graph.

Duration of antibiotic therapy in sepsis and severe infections in critically ill patients.

American journal of respiratory and critical care medicine·2026

The emerging role of PDE4 inhibitors for the treatment of pulmonary fibrosis.

Expert review of clinical pharmacology·2026

Cefepime and Mortality: A Systematic Review and Bayesian Meta-Analysis.

JAMA network open·2026

Acute Supraglottitis in Pediatric Patients-An Emerging Disease?

Pediatric pulmonology·2026

Screening for multidrug resistance carriage and appropriate initial antibiotic treatment of intensive care unit-acquired bloodstream infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Cell-free tumour DNA in bronchoalveolar lavage: a proof of concept study.

ERJ open research·2026

Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial.

The Lancet. Respiratory medicine·2026

Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis.

The Lancet. Respiratory medicine·2026

State-level burden of chronic respiratory diseases in the USA, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Respiratory medicine·2026

Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohort.

The Lancet. Respiratory medicine·2026

Risk factors for hospital admission and mortality in patients with influenza virus infection: a systematic review and meta-analysis.

The Lancet. Respiratory medicine·2026

Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in children with cystic fibrosis aged 2-5 years (TIMBERLINE Trial VX21-121-105): a phase 3, open-label study.

The Lancet. Respiratory medicine·2026

Expanding the clinical spectrum of Lemierre syndrome and Lemierre-like septic internal jugular vein thrombophlebitis: a four-case series.

Frontiers in medicine·2026

Inhibiting trained immunity in Duchenne muscular dystrophy enhances muscle regeneration and reduces fat deposition.

Research square·2026

Autoantibodies neutralizing type I interferons in patients with life-threatening COVID-19 pneumonia: a meta-analysis from 2020-2026.

medRxiv : the preprint server for health sciences·2026

RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation.

bioRxiv : the preprint server for biology·2026

Tissue-resident memory B cells augment local anti-cancer immunity via IgA.

bioRxiv : the preprint server for biology·2026

First-in-Human, Randomized, Placebo-Controlled, Double-Blind Phase 1 Study to Assess in Healthy Adults the Safety and Immunogenicity of Intramuscularly Administered AAVLP-HPV Vaccine.

medRxiv : the preprint server for health sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us